Clinical Trials Directory

Trials / Completed

CompletedNCT03453385

Clinical Outcomes of a Nationwide, Naturalistic E-Cig Trial (CONNECT)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
638 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to measure changes in smoking behavior during and following sampling of an e-cigarette product. E-cigarettes are classified by the US Food and Drug Administration (FDA) as a tobacco product, though they contain no tobacco. Unlike regular cigarettes, which are burned (creating smoke that is inhaled), e-cigarettes include a heating element that vaporizes nicotine. E-cigarettes are likely much safer than conventional cigarettes, but they may not be entirely safe. We are testing the effects of one specific ecigarette (NJoy) on naturalistic changes in smoking behavior. Neither the tobacco industry nor any ecigarette manufacturer provides support of any kind to this study. There is no requirement to quit smoking in this study, nor is there any requirement to use e-cigarettes.

Detailed description

Eligible smokers, once consented, will be randomized to receive a sample of ecigarettes (NJoy Pre-Filled Tank; n=440) or not (n=220). E-cigarette samples are inclusive of a battery and self-contained tanks of assorted flavors to last up to 4 weeks. Participants will be recruited nationally, but a subset (N=120) will be recruited locally to allow for biomarker collection . Our two-fold purpose is to 1) characterize naturalistic uptake of e-cigarettes, and 2) assess impact of e-cigarette uptake on smoking behavior. All smokers will be asked to provide smoking diary data, captured electronically, daily for 4 weeks. More substantive phone assessment will track smoking and related behaviors at baseline (Day 0) and +10, +17, and +24 days (weekly during initial 3 weeks, following brief lag for delays in product mailing), and at +1, +3, and +6 months.

Conditions

Interventions

TypeNameDescription
BEHAVIORALElectronic CigaretteAn e-cigarette and four weeks of e-liquid provided to participants.

Timeline

Start date
2018-05-24
Primary completion
2022-09-08
Completion
2022-09-08
First posted
2018-03-05
Last updated
2023-09-11
Results posted
2023-09-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03453385. Inclusion in this directory is not an endorsement.